07:00 , May 11, 2015 |  BC Week In Review  |  Financial News

Boston Scientific completes private placement of senior notes

Boston Scientific Corp. (NYSE:BSX), Natick, Mass.   Business: Cardiovascular   Date completed: 2015-05-07   Type: Private placement of senior notes   Raised: $1.9 billion   Investor: Existing investors   Underwriters: Barclays Capital; Citigroup; Deutsche Bank;...
07:00 , Apr 6, 2015 |  BC Week In Review  |  Financial News

UCB completes bond

UCB Group (Euronext:UCB), Brussels, Belgium   Business: Neurology, Autoimmune, Inflammation   Date completed: 2015-03-27   Type: Bond   Raised: EUR350 million ($379.1 million)   Investor: Institutional investors   Underwriters: BNP Paribas; BofA Merrill Lynch; Societe...
08:00 , Feb 21, 2011 |  BC Week In Review  |  Financial News

Philogen withdraws IPO

Philogen S.p.A. , Siena, Italy   Business: Cancer, Autoimmune, Ophthalmic   Date announced: 2/15/11   Type: IPO   Underwriters: Banca IMI; UBS   Note: Philogen withdrew its IPO on the Milan Stock Exchange after Bayer...
02:03 , Feb 16, 2011 |  BC Extra  |  Financial News

Philogen withdraws IPO after Bayer ends deal

Philogen S.p.A. (Siena, Italy) withdrew its IPO after Bayer AG (Xetra:BAY) terminated a 1999 cancer deal related to the Italian biotech's L19 antibody. Earlier this month, Philogen said it planned to raise up to EUR...
08:00 , Feb 14, 2011 |  BC Week In Review  |  Financial News

Philogen proposes IPO

Philogen S.p.A. , Siena, Italy   Business: Cancer, Autoimmune, Ophthalmic   Date announced: 2/8/11   Type: IPO   To be raised: Up to €65.3 million ($88.9 million)   Shares: 10.7 million   Price: €4.75-€6.10  ...
08:00 , Feb 14, 2011 |  BioCentury  |  Finance

Philogen up

Last week, angiogenesis-focused Philogen S.p.A. disclosed details of its IPO. The Italian company plans to sell up to 10.7 million shares at €4.75-€6.10 in an IPO on the Milan Stock Exchange. That would raise up...
02:18 , Feb 11, 2011 |  BC Extra  |  Financial News

Philogen sets IPO range

Philogen S.p.A. (Siena, Italy) said it plans to raise up to EUR 65.3 million ($88.9 million) through the sale of up to 10.7 million shares at EUR 4.75-EUR 6.10 in an IPO on the Milan...
07:00 , Aug 9, 2010 |  BC Week In Review  |  Financial News

MolMed financial update

MolMed sold an additional 2.1 million shares in its July rights offering, raising an additional €1.1 million ($1.5 million) and bringing the total raised in the offering to €57.9 million ($74.7 million). Underwriters Jefferies and...
07:00 , Jul 26, 2010 |  BC Week In Review  |  Financial News

MolMed completes rights offering

MolMed S.p.A. (Milan:MLM), Milan, Italy   Business: Cancer   Date completed: 7/20/10   Type: Rights offering   Raised: €56.7 million ($73.2 million)   Shares: 103.1 million   Price: €0.55   Shares after offering: 208.3 million...
07:00 , Jun 28, 2010 |  BC Week In Review  |  Financial News

MolMed proposes rights offering

MolMed S.p.A. (Milan:MLM), Milan, Italy   Business: Cancer   Date announced: 6/24/10   Type: Rights offering   To be raised: Up to €57.9 million ($71.9 million)   Price: €0.55   Shares: 105.2 million   Underwriters:...